Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 975 of 2873 entries
View as:

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01454804 Org: User:
Start: 10/31/11 End: 03/31/15 Due: 03/31/16

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

Phase: N/A Priority: Normal
NCT ID: NCT03604315 Org: User:
Start: 12/18/18 End: 06/30/27 Due: 06/30/28

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

Phase: N/A Priority: Normal
NCT ID: NCT06287229 Org: User:
Start: 07/11/24 End: 12/31/30 Due: 12/31/31

Genetic Study of Chronic Lymphocytic Leukemia Families

Phase: N/A Priority: Normal
NCT ID: NCT00503256 Org: User:
Start: 09/30/03 End: 09/30/19 Due: 09/30/20

Registry for Women Who Are At Risk Or May Have Lynch Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00508573 Org: User:
Start: 05/31/07 End: 08/05/24 Due: 08/05/25

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05337735 Org: User:
Start: 08/05/22 End: 04/01/26 Due: 04/01/27

Data Collection Protocol for Patients With Von Hippel Lindau Disease

Phase: N/A Priority: Normal
NCT ID: NCT05955014 Org: User:
Start: 08/24/23 End: 12/31/26 Due: 12/31/27

Using Focus Groups to Assess the Impact of Environmental Health Science Programs for K-12 Educational Community

Phase: N/A Priority: Normal
NCT ID: NCT00428402 Org: User:
Start: 01/31/07 End: 02/29/12 Due: 02/28/13

High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01237951 Org: User:
Start: 11/08/10 End: 09/20/17 Due: 09/20/18

REVOLVE or PureGraft Technique in Processing Fat Grafts for Patients Undergoing Breast Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT03502512 Org: User:
Start: 02/13/18 End: 08/06/21 Due: 08/06/22

Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)

Phase: N/A Priority: Normal
NCT ID: NCT00129740 Org: User:
Start: 06/27/05 End: 07/11/18 Due: 07/11/19

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005092 Org: User:
Start: 05/28/99 End: 08/28/02 Due: 08/28/03

Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01729104 Org: User:
Start: 04/25/13 End: 10/03/18 Due: 10/03/19

Metformin in Non Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT02285855 Org: User:
Start: 02/20/15 End: 01/05/19 Due: 01/05/20

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04940299 Org: User:
Start: 09/23/21 End: 12/31/25 Due: 12/31/26

Barriers Affecting Physical Activity

Phase: N/A Priority: Normal
NCT ID: NCT03573375 Org: User:
Start: 06/20/18 End: 11/12/21 Due: 11/12/22

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04199026 Org: User:
Start: 02/25/25 End: 12/31/25 Due: 12/31/26

Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00525915 Org: User:
Start: 04/30/05 End: 03/31/13 Due: 03/31/14

Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial

Phase: N/A Priority: Normal
NCT ID: NCT06736600 Org: User:
Start: 04/18/25 End: 08/31/27 Due: 08/31/28

First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging

Phase: N/A Priority: Normal
NCT ID: NCT05335811 Org: User:
Start: 10/06/22 End: 12/31/24 Due: 12/31/25

Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases

Phase: N/A Priority: Normal
NCT ID: NCT00038857 Org: User:
Start: 09/30/01 End: 06/30/09 Due: 06/30/10

Acceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04693364 Org: User:
Start: 12/27/17 End: 02/22/22 Due: 02/22/23

Lifestyle Intervention for High Risk Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT01508273 Org: User:
Start: 05/31/12 End: 12/31/15 Due: 12/31/16

Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00002463 Org: User:
Start: 02/28/89 End: 01/31/08 Due: 01/31/09

A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women

Phase: N/A Priority: Normal
NCT ID: NCT01605656 Org: User:
Start: 07/31/12 End: 04/30/15 Due: 04/30/16